Thus, DDR inhibitors can not only inhibit DNA repair and increase the sensitivity of radiotherapy, but also increase the number of micronucleus and small fragments of DNA in tumor cells induced by radiotherapy, and further activate the cGAS-STING pathway and the expression of type 1 IFN. This evidence concerns the gene STING1 and neoplasm.